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Male fertility is a highly controlled process that allows proliferation, meiosis and differentiation of male germ cells in the testis, final
maturation in the epididymis and also requires functional male accessory glands: seminal vesicles, prostate and corpus cavernosum. In addition to
classical endocrine and paracrine controls, mainly by gonadotropins LH and FSH and steroids, there is now strong evidence that all these
processes are dependent upon the presence of homocellular or heterocellular junctions, including gap junctions and their specific connexins (Cxs),
between the different cell types that structure the male reproductive tract. The present review is focused on the identification of Cxs, their
distribution in the testis and in different structures of the male genital tract (epididymis, seminal vesicle, prostate, corpus cavernosum), their crucial
role in the control of spermatogenesis and their implication in the function of the male accessory glands, including functional smooth muscle tone.
Their potential dysfunctions in some testis (spermatogenic arrest, seminoma) and prostate (benign hyperplasia, adenocarcinoma) diseases and in
the physiopathology of the human erectile function are also discussed.
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Testis exerts two major functions, an endocrine function
characterized by synthesis of androgens, and an exocrine
function via spermatogenesis. Spermatogenesis, which takes
place within seminiferous tubules, is a highly controlled
process that may be divided into three principal phases:
spermatogonia renewal and proliferation, spermatocyte meiosis
and spermatid differentiation [1]. In addition, developing germ
cells must progressively migrate from the basal to the luminal
compartment of seminiferous tubules so that fully differenti-
ated spermatids can be released into the lumen at spermiation.
Within the seminiferous epithelium, spermatogenesis is sup-
ported by Sertoli cells that provide structural and nutritional
supports for the developing germinal cells (reviewed in Ref.
[2]).
Spermatogenesis requires a functional hypothalamo-pitui-
tary system involving Luteinizing hormone (LH) and Follicle
stimulating hormone (FSH) and a local control via paracrine
signals. FSH regulates spermatogenesis via stimulating the
proliferation of Sertoli cells during the neonatal period. LH
indirectly controls spermatogenesis through androgens pro-
duced by Leydig cells located in the interstitial compartment
between seminiferous tubules. Androgens play also a primor-
dial role in the initiation and maintenance of the male
reproductive tract. Testosterone is the predominant circulating
androgen and is necessary for the differentiation of the
Wolffian ducts into the seminal vesicles, epididymis, and
ejaculatory ducts. The 5-a reduced product of testosterone,
dihydrotestosterone, is needed for the differentiation of the
urogenital sinus and genital tubercle into the prostate, urethra,
penis, and scrotum (reviewed in Ref. [3]).
Local cell–cell interactions including direct contact-depen-
dent junctional pathways are also essential in the regulation of
mammalian spermatogenesis and in the maintenance of the
male phenotype [4,5]. These cellular junctions are composed of
specialized proteins implicated in adhesion (such as cadherin–
catenin, nectin, integrin and others) and attachment (such as
occludin, claudins, Zonula occludens and others) (reviewed in
Ref. [6]). A third type of junctions present in the testis and in
the male genital tract (epididymis, seminal vesicle, prostate,
corpus cavernosum) concerns gap junctions and their consti-
tutive proteins, connexins (Cxs).
The present review has been designed to update the recent
developments on Cx identification in the male reproductive
tract and their role on male fertility.
2. Gap junction channels and connexins
Gap junctions are clusters of plasma membrane channels
formed of Cxs, which allow direct intercellular exchange ofmolecules of molecular weight smaller than 1 kDa (ions and
signaling mediators) between the cytoplasmic compartments of
two adjacent cells (reviewed in Ref. [7]). Today, at least 20 Cxs
differentiated by their molecular weights are identified
(reviewed in Ref. [8]). They are expressed in a tissue-specific
manner and various cell types exhibit more than one Cx. Cxs
oligomerize to form two juxtaposed hemichannels termed
connexons, which are defined as homomeric when composed
of the same Cx or heteromeric when at least two different Cxs
form the connexon. Gap junctional intercellular communica-
tion (GJIC) is involved in the regulation of cell growth and
differentiation, homeostasis and neoplastic transformation
(reviewed in Ref. [9]). Recent studies have reported that Cxs,
by themselves, can play critical functions in signal transduc-
tion, independent of forming intercellular channels (reviewed
in Ref. [10]).
3. Gap junction and connexin expression in the testis
Testicular gap junctions were first described by electron
microscopy in the rat testis [11]. By using freeze fracture
electron microscopy and analysis of the junctional permeability
with fluorescent dyes, the presence of these junctions was
further reported in the testis of rodents prior to and during the
initiation of spermatogenesis [4,12–14].
In the mature rat testis, mRNA for eleven different Cxs (e.g.,
Cx26, Cx30.2, Cx31, Cx31.1, Cx32, Cx33, Cx37, Cx40, Cx43,
Cx46 and Cx50) have been detected [15–20]. Ten of the Cx
mRNAs examined were present in polysomes and presumably
translated in adult seminiferous tubules [19]. Transcripts for
Cx26, Cx30.3, Cx31, Cx31.1, Cx32, Cx37, Cx40, Cx43, Cx45
and Cx46 were also found in the fetal mouse testis [21].
3.1. Gap junction and connexin expression within the
seminiferous epithelium
Within the seminiferous tubules, gap junctions are located in
the region of Sertoli cell occluding junctions at the level of the
blood–testis barrier [22,23] and between Sertoli and germ cells
[24,25]. The distribution of Cx mRNA and protein in the
different cell types of the testis is summarized in Table 1.
Cx43, the predominant Cx in the testis, is located in the
basal compartment of the seminiferous tubules in rat [26–28],
guinea pig, mink [29] and human [30,31]. The specific
distribution of Cx43 within the seminiferous epithelium was
evidenced by in situ hybridization experiments demonstrating
that Cx43 mRNA was expressed by Sertoli cells and basally
located germ cells such as spermatogonia and spermatocytes in
testes of rat [32] and human [31,33]. Deconvolution micros-
copy analysis, which allows a better resolution that confocal
analysis, clearly indicated that Cx43 was mainly present at the
Table 1
Localization of Cx mRNA and proteins in the testis
Cx Species Testicular cell types in which Cx mRNA and proteins are detected References
Cx26 mouse, rat Spermatocytes, spermatids (RT-PCR) [19]
Apical compartment of seminiferous tubules (IHC) [26]
human Seminiferous tubules (cell type not identified) [49]
Cx30.2 mouse Leydig cells and endothelial cells (IHC) [20]
Cx31 rat Spermatocytes, spermatids and peritubular cells (RT-PCR) [19]
Spermatogonia, spermatocytes (ISH, IHC) [47]
Cx31.1 rat mRNA detected in the testis but unknown localization [19]
Cx31.9 human Vascular smooth muscle [20,50]
Cx32 rat, mouse Spermatocytes, spermatids and Sertoli cells (RT-PCR) [19]
Apical compartment of seminiferous tubules (IHC) [26]
fish Sertoli cells, spermatogonia and spermatocytes (WB; IHC) [40]
Cx33 rat, mouse Sertoli cell (WB, IHC) [41,43,44]
Spermatocytes and spermatids (RT-PCR) [19,45]
Cx37 rat Peritubular cells (RT-PCR) [19]
Endothelial cells (IHC) [41]
Cx40 rat Spermatocytes, spermatids and peritubular cells (RT-PCR) [19]
human Testicular cell types not identified (RT-PCR) [51]
Cx43 rat, mouse Sertoli cells, Leydig cells, peritubular cells (IHC, IG, RT-PCR) [26,28,29,32,43,52,55,60,65,76,110]
Guinea pig, mink Sertoli cells, Leydig cells (IHC) [29]
human Sertoli cells, Leydig cells, spermatogonia (ISH, IHC) [30,31,49]
frog Sertoli cells, Leydig cells, spermatogonia (IHC) [52]
Cx45 rat Peritubular cells (RT-PCR) [19]
Cx50 rat Spermatocytes, spermatids (RT-PCR) [19]
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Sertoli cell specific marker) in close association with adjacent
Sertoli cells and with vimentin-negative cells that are likely
germ cells (Fig. 1). At this compartmental level, Cx43
colocalized with occludin, a tight junction protein [34] and
with the associated tight junction protein, Zonula Occludens-1
(ZO-1) [28]. However, a more discriminating analysis of Cx43
and ZO-1 signals reveals that, in all cases examined, a close
colocalization was often unusual [35]. Such an absence of
complete association between Cx43 and ZO-1 was also
reported in myocytes [36].
Dye coupling experiments performed in situ, with a large
variety of low-molecular-weight tracers, reveal that there are
multiple routes of GJIC in rat seminiferous tubules that differ in
permeability properties and show alternative gating states [37].Fig. 1. Localization of Cx43 in a cross section of the adult rat testis. (A) The Cx4
seminiferous tubules and in the interstitial compartment between Leydig cells. Not
Leydig, germ and Sertoli cells were identified by DAPI staining (blue fluorescenc
compartment of a rat seminiferous tubule at stage V of spermatogenesis (600). Th
Cx43 staining (red fluorescence) is located at the base of the Sertoli cell and present
Sertoli cells were identified by DAPI staining (blue fluorescence). s: Sertoli cell; g:
spermatid.By developing a sophisticated in situ assay that allows
correlating dye transfer, cell type identification and Cx43
localization, we showed that Cx43 participates in the coupling
between adjacent Sertoli cells, between Sertoli cells and
spermatogonia, between Sertoli cells and early and late
spermatocytes but not between Sertoli cells and spermatids
[38]. Our study also indicates that the coupling, analyzed with
Lucifer yellow, appeared unidirectional from Sertoli cells to
germ cells, whereas no transfer of this dye was observed from
germ cells to the somatic cells. These data are in agreement
with those reported by other authors but do not exclude that
other low-molecular-weight tracers that differ in their physi-
cochemical properties could diffuse from spermatogonia to
Sertoli cells. According to Risley et al., this asymmetric
coupling would facilitate the concentration in germ cells of3 immunosignal (red fluorescence) is located in the basal compartment of the
e that the Cx43 signal is dependent upon the spermatogenic stages. Nuclei of
e) (60). (B) High-resolution deconvolution microscopy analysis of the basal
e vimentin filaments (green fluorescence) underline the Sertoli cell cytoplasms.
close contact with vimentin filaments. Nuclei of early and late germ cells and of
spermatogonia; p: pachytene spermatocyte; rs: round spermatid; es: elongated
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From altogether these data, it has been suggested that gap
junctions present between these two cell types may participate
in the control exerted by Sertoli cells on germ cells.
A specific feature of spermatogenesis is that the dividing
germ cells fail to complete cell division resulting in the
formation of cytoplasmic bridges. These structures intercon-
nect a large number of germ cells and allow synchronous
development of these cells by sharing gene products [39]. The
possibility that gap junctions in concert with cytoplasmic
bridges participate in exchanges between germ cell cyto-
plasms must be considered. In fish, where spermatogenesis
occurs in cysts rather than in seminiferous tubules, gap
junctions were characterized between germ cells [40].
However, no gap junctions were described between germ
cells in mammals.
The presence of Cx43 was also detected in residual bodies,
the excess of germ cell cytoplasms which are phagocytosed by
Sertoli cells during spermiation (unpublished data). Whether
this Cx accumulation reflects a degradation mechanism of the
protein or is related to another unknown role of Cx in residual
bodies is presently not clear.
In contrast to Cx43 which was mainly located in the basal
compartment of seminiferous epithelium, Cx26 and Cx32 were
only found in the apical region of the rat seminiferous tubules
but the cell types which express these Cxs were not identified
[26]. Cx30.2, the putative mouse orthologue of human Cx31.9,
was detected at high levels in vascular smooth muscle cells and
at a low level between Sertoli and germ cells, and in Leydig
cells [20].
In rat and mouse, Cx33 is mainly restricted to the testis
[17,41] and to hippocampal multipotent progenitor cells [42].
Immunohistochemical studies demonstrated that Cx33 was
present in the basal compartment of seminiferous tubules and
not found in Leydig cells [41,43]. Its presence was clearly
shown in Sertoli cells when immunohistochemistry analysis
was performed on testis sections [44] and in vitro in a Sertoli
cell line [43]. Other data reported that Cx33 was not only
restricted to Sertoli cells but was also detected by RT-PCR in
both crude preparation of germ cells [45] and in enriched
preparations of mature male germ cells such as pachytene
spermatocytes and round spermatids [19]. However, due to
the difficulty to obtain pure fractions of germ cells, the
presence of Cx33 transcripts in these cell preparations is
doubtful. Another typical feature of Cx33 is that its
expression is different from that of Cx43. While the intensity
of the immunoreactive signal for Cx43 was markedly reduced
in the abdominal testis of a cryptorchid mutant rat, Cx33 was
maintained at a high level in Sertoli cells (Fig. 2, upper
panels). As observed above for the protein, semiquantitative
analysis of Cx33 and 43 transcripts reveals that the level of
Cx33 mRNA was not altered in the cryptorchid testis while
Cx43 was significantly reduced in the pathological testis (Fig.
2, lower panels). The reasons for these discrepancies have not
yet been elucidated. Another interesting point is that Cx33, in
contrast to other Cxs, has been reported to exert a Cx-specific
inhibitory effect on GJIC when mRNAs were microinjectedinto paired Xenopus oocytes [46]. In Sertoli cells, our
laboratory demonstrated that sequestration of a Cx33/Cx43
complex was associated with a complete inhibition of the
junctional coupling between adjacent cells [43]. These
findings provide the first evidence of a new mechanistic
model by which a native Cx, exerting a dominant negative
effect, can inhibit GJIC.
Within the testis, other Cxs have been only detected in germ
cells. Cx31 mRNA was specifically localized by in situ
hybridization in spermatogonia and early spermatocytes
(leptotene and zygotene) and its presence was confirmed by
the detection of an immunoreactive signal in the cytoplasms of
the male germ cells [47]. These authors were, however, unable
to detect Cx31 mRNA and protein in Sertoli cells. The role of
Cx31 in the formation of heterocellular junctions between
Sertoli cells and spermatogonia or early spermatocytes is today
unclear since it has been previously demonstrated that, in HeLa
cells, this Cx was unable to associate with other Cxs present
within the seminiferous tubule [48]. RT-PCR analysis of
partially purified testicular cells indicates that Cx50 mRNA
could be limited to germ cells: pachytene spermatocytes and
round spermatids but the tissular distribution of Cx50 protein
was not investigated [19]. Thus, it is possible that Cx31 and
Cx50 exert specific function(s).
To date, there is little information on the identity of Cxs
present in the human testis. Cx43 mRNA and protein are
present within the seminiferous tubules and in Leydig cells
[30,31]. Cx26 has been characterized within seminiferous
tubules [49] and Cx31.9 in testicular vascular smooth muscle
[20,50]. By developing a cDNA microarray representing
23,040 genes, Cx40 transcripts were detected in the human
testis but no information on the precise localization of Cx40
protein was given [51]. At least, no orthologue of the rat
specific testis Cx33 was demonstrated in human [8,44].
However, the lack of Cx33 orthologue in man does not
preclude that another member of the Cx family might exert in
human similar effects than those reported by Cx33 in the rodent
testis [43].
The presence of Cxs or of gap junction proteins homologous
to invertebrate, innexins, has been also described in the testes
of other species such as frog [52], fish [40,53] and Drosophila
[54].
3.2. Gap junctions and connexin43 expression in the interstitial
compartment
Gap junctions are also present in the interstitial compart-
ment between Leydig cells. Gap junction coupling occurs
between freshly isolated mouse Leydig cells and in the TM3
Leydig cell line as demonstrated by dye coupling analysis and
electrophysiological measurements [55,56]. In contrast to the
seminiferous epithelium in which many Cxs were found, Cx43
was the only Cx detected in Leydig cells of different species
such as rat, mouse, guinea pig, mink, frog and human
[26,28,29,32,52,55]. In addition, Cx37 was present in the
interstitial compartment but specifically located in the endo-
thelial cells of the blood vessels [26].
Fig. 2. Analysis of Cx33 and Cx43 expressions within the seminiferous tubules of a mutant cryptorchid rat. (Upper panel) Immunolocalization of Cx33, green
fluorescence (B and E) and Cx43, red fluorescence (C and F) in the control scrotal (B and C) and abdominal cryptorchid (E and F) testes of the mutant rat.
Histological analysis confirms the lack of germ cells within the seminiferous tubules of the abdominal testis (D) as compared to the control testis (A). (Lower panel)
Cx33 and Cx43 mRNA measured by RT-PCR in control (white columns) or abdominal testes (black columns) of the mutant rat. The amounts of amplified products
were quantified for each sample by densitometric analysis and results were expressed as the average ratios of the relative optical densities (ROD) of Cx33 or Cx43
PCR products to that of h-actin as previously described [31]. Values are the meanTS.E.M. of five densitometric readings in five separate experiments. A one-way
analysis of variance and a Student’s t test were used for comparisons between groups. Means were considered significantly different for P <0.05.
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In the testis, there is now clear evidence that Cx gene
expression may be related to the development and to the
stages of the seminiferous epithelium, characterized by the
association of specific germ cells. Cx gene expression profiles
in fetal and adult testes, studied by serial analysis of gene
expression (SAGE), revealed that Cx43 transcripts were
present in Sertoli cells of the fetal testis but at a higher
frequency in adult animals [57]. It has been reported, by
cDNA microarray, that Cx26 and Cx40 expressions were up-
regulated from primitive type A spermatogonia to type B
spermatogonia, whereas Cx26 was down-regulated from type
B spermatogonia to preleptotene spermatocytes [58]. The
reasons for these changes in Cx gene expression during
testicular development and between spermatogenic stages are
presently unclear.Within the seminiferous epithelium, immunoreactive Cx43
has been detected between Sertoli and germ cells in newborns
and at the time of initiation of spermatogenesis [32,59,60].
During testicular maturation, the signal shifts from the apical to
the basal regions of seminiferous tubules in rat [41] and mouse
[32,61].
One of the most important events of Cx43 appearance when
spermatogenesis takes place is the concomitant location with
tight junction molecules preceded by focal adhesion. Generally,
there is evidence that adhesion molecules are prerequisite for
gap junction formation since it has been reported that the
addition of N-cadherin antibodies to Novikoff cell culture
blocks the gap junction appearance [62]. In the testis, adhesion
molecules such as N-cadherin and a-catenin appear before gap
junctions can be detected [63]. By using a Sertoli cell line that
expresses Cx43 [64,65], we reported that adhesion molecules
(N-cadherin and a-catenin) were first distributed in the
G. Pointis et al. / Biochimica et Biophysica Acta 1719 (2005) 102–116 107cytoplasm and secondly as dots at the plasma membrane (data
not shown). Cx43 was later detected in the cytoplasm of these
cells. Then, concomitantly, tight junction molecules and Cx43
were distributed at the cell–cell contact of adjacent cells. Such
progressive reorganization of testicular Cx43 is probably under
the control of the Sertoli cytoskeletal elements as noticed in
other cell types [66]. Altogether these data emphasized that
Cx43 appears early during spermatogenesis and that this
process follows a precise sequence of events, in relation with
its partner molecules.
Another interesting feature is that the levels of Cx43
protein increased during the first wave of spermatogenesis
when specifically measured within the seminiferous tubules
(Fig. 3). In contrast, the expression of another component of
the junctional complex, such as occludin, which is known to
participate in the formation of tight junctions (reviewed in
Ref. [6]) was not markedly altered during testicular
development.
3.4. Control of connexin expression in the testis
The majority of the hormonal factors control the function of
their respective tissue or cellular targets in part through gap
junction modulation. Such process occurs in the endocrine,
immunological and nervous systems: TSH for thyroid; T3, T4
for liver; epinephrine for heart; oxytocin for uterus; LH and
FSH for ovary (see for review [67]). In the testis, despite theFig. 3. Immunodetection of Cx43 (a marker of gap junctions) and of occludin (
maturation. At stages of 20, 28 and 40 days of development, testes were fixed
immunodetected with specific antibodies as reported [28]. Note that the immunosign
occludin signal does not show any change during the same developmental period.well-documented presence and indispensability of several Cxs,
little is known on the physiological effectors capable of
regulating cell–cell communication and the steps that are
potential sites of the control of gap junctions.
There is now clear evidence that Cx43 mRNA and protein
expressions are dependent upon the stages of spermatogenic
cycle and that the higher levels are detected at stage VII
compared to other stages in rat and mouse testes [26,28,29,
32,41,65]. This stage-dependent expression of Cx43 has been
also described in the human testis [30,31]. Analysis of Cx43
protein in testes of mutant mice with impaired spermatogenesis
led to suggest the existence of a close relationship between the
presence of germ cells and Cx43 and the possibility that a
specific germ cell population, such as late spermatids, control
Cx43 in Sertoli cells [28]. However, the exact mechanisms
have not yet been elucidated.
Gap junctions between Sertoli cells, between Sertoli and
germ cells, and between Leydig cells may be subject to
endocrine and paracrine controls. However, limited informa-
tion is available on the identity of the factors that control Cx
gene expression in the testis. There is evidence that gap
junction coupling between Sertoli cells in primary culture is
up-regulated by Follicle stimulating hormone, FSH [68]. Its
second messenger cAMP is also capable of potentiating GJIC
and of altering Cx43 levels [65]. The electrical coupling
measured in the presence of cAMP was inhibited when intact
seminiferous tubules or isolated cells were incubated in a Ca++-a marker of tight junctions) within seminiferous tubules during rat testicular
, cut and Cx43 (green fluorescence) and occludin (red fluorescence) were
al for Cx43 markedly increased from day 20 to day 40 while the intensity of the
G. Pointis et al. / Biochimica et Biophysica Acta 1719 (2005) 102–116108free medium suggesting that Ca++ is necessary for cAMP
responsiveness [69].
The possibility that steroids can control GJIC between
adjacent Sertoli cells has been considered. Indeed, esterified
forms of testosterone and of 17h-estradiol, and at a lower level,
the nonesterified sexual steroids, markedly down-regulated the
electrical and diffusional couplings between rat Sertoli cells in
primary culture [70,71]. From these results, it has been
suggested that lipophilic molecules, such as steroids, could
disturb the function of membrane proteins and that, among
them, Cx could be one of the molecular targets. A direct
interaction of the steroid with the proteolipidic membranous
structure and a modification of the Ca++ signal between Sertoli
cells in response to testosterone, is in agreement with such an
hypothesis [72].
Plasmalogens, the major mammalian ether lipids ( EL)
analogous to cholesterol, are known to control diverse
physiological processes such as modulation of membrane
fluidity, participation in signal transduction, facilitation of
membrane fusion [73]. Recent findings indicate that inactiva-
tion of ether lipid biosynthesis in mutant mice caused male
infertility and down-regulated Cx43 suggesting that ELs can
affect the control exerted by gap junctions on spermatogenesis
[74]. The exact mechanism(s) by which these compounds
control Cx43 gene expression is presently unknown.
Thyroid hormones are known to play an important role in
testicular development and function and exert a specific
influence on Sertoli cell proliferation and differentiation during
the neonatal period [75]. It has been shown that propylthiour-
acil (PTU), which is known to induce neonatal hypothyroidism
in rats, led to a delocalization of Cx43 from the cell plasma
membrane to the cytoplasm of Sertoli cells without altering
Cx43 mRNA and protein levels in PTU-treated rat testis [76].
From these data, it has been postulated that, in Sertoli cells,
thyroid hormones mainly control Cx43 intracellular trafficking
rather than its transcription as previously reported in rat liver
epithelial cells [77,78].
Retinoids, which are known to be implicated in cell cycle
regulation and cell–cell interaction, are essential for both
normal growth and differentiation of germ cells and mainte-
nance of spermatogenesis in the mammalian testis (reviewed in
Ref. [79]). We reported that testicular Cx43 expression was
reduced in transgenic mice invalidated for the retinoid X
receptor h (RXRh/), which show Sertoli cell dysfunction.
From these observations, we concluded that retinoids through
RXRh receptors could participate in the control of Cx43 gene
expression in Sertoli cell [32]. Such a hypothesis has been
validated by a recent findings indicating that vitamin A
treatment restored testicular Cx43 expression in a vitamin A-
deficient rat model with impaired spermatogenesis [80]. There
is also evidence that in many tissues, Cx43 expression is under
the regulation of transcriptional factors such as the Fos and Jun
subfamilies [81]. Such a regulation probably occurs in the
testis, since we reported that jun-d null mice exhibited
simultaneously altered spermatogenesis and a marked reduc-
tion or abolishment of Cx43 within the seminiferous tubules
[28].Leydig cells, the somatic cells present in the interstitial
compartment and responsible of androgens synthesis,
responded in vitro to human chorionic gonadotropin (hCG)
exposure by reducing Cx43 mRNA and protein levels and
inducing a cellular redistribution of the protein [82].
Activators of protein kinase A (PKA) and protein kinase C
(PKC) similarly affected Cx43 expression in the TM3 Leydig
cell line [83]. In contrast, an inhibitor of protein kinases,
staurosporine, was capable to prevent and reverse the
uncoupling effect of dibutyryl cAMP and 12-O-tetradeca-
noyl-phorbol-13-acetate (TPA) suggesting that cell–cell com-
munication between Leydig cells is down-regulated by both
PKA and PKC, interacting in a complex manner [56]. As
reported above for Sertoli cells, Cx43 expression in Leydig
cells, also appears regulated during fetal and post natal
development in an age- and function-dependent manner
[59,60]. In the interstitial compartment, the relative temporal
correlation between the increase in the number, the size of
Leydig cells as well as their Cx43 expression during neonatal
life is consistent with the possibility that Cx43 participates in
the control of developmental processes involved in testoster-
one production and secretion [59]. Between mature Leydig
cells, Cx43 based gap junctions might locally coordinate the
androgenic activity in relation with the stages of spermato-
genesis [26].
3.5. Role and functional significance of gap junction and
connexins in the testis
There are many indirect observations in support of a role of
Cx43 in the control of spermatogenesis. (1) Cx43 forms
intercellular contacts between Sertoli cells and proliferating
germ cells suggesting that Cx43 participates in specific
spermatogenic steps [38]. (2) Cx43 levels are reduced or
undetectable within the seminiferous tubules of mutant rat and
mice with impaired spermatogenesis [28,31]. (3) Cx43
expression and GJIC are controlled in a stage-dependent
manner indicating the existence of a close relationship between
the association of specific germ cells and Cx43 expression
within the seminiferous tubules [26,28,32,41].
The direct demonstration of Cx43 involvement in sper-
matogenesis derives from data in Cx null mutant mice (Table
2). Although Cx43 deficient mice die at birth of cardiac
malformation [84], it has been reported that testes from null
mutant fetuses exhibited a 50% depletion in primordial germ
cells indicating that Cx43 participates in the control of germ
cell proliferation during fetal development [85]. Similarly,
testes from Cx43 null mutant fetuses did not allow normal
proliferation and differentiation of germ cells when grafted
under the kidney capsules of adult males [86]. The essential
role of Cx43 in spermatogenesis comes from original data in
which the coding sequence of the Cx43 gene was substituted
by coding sequences of Cx32 or Cx40 [87]. These two lines of
knock-in mice were viable but the males Cx43KI32 and
Cx43KI40 were sterile, exhibiting a Sertoli-cell-only (SCO)
phenotype, with seminiferous tubules totally depleted in germ
cells. The detailed mechanism(s) that conduces to sterility of
Fig. 4. Effect of oleamide, a blocking agent of GJIC, on germ cell proliferation.
Oleamide (50 AM) diluted in DMSO was microinjected in the testes of 5 mature
rats (90 days old). For each animal, the contralateral testis was injected with the
vehicle alone and used as control. Control and treated testes were embedded in
paraffin and cut to perform 5 Am sections. Tissue sections were prepared for
fluorescence observations with Vectashield and DAPI mounting medium after
hydration of the slides. The number of germ cells, identified by DAPI staining,
was quantified using Visilog 5 software (Noesis) in 30 seminiferous tubules
two and 3 weeks after microinjection. For each testis, 100 sections were
examined. A one-way analysis of variance and a Student’s t test were used for
comparisons between groups. *P <0.05, **P <0.01 as compared to testes
injected with the vehicle alone.
Table 2
Analysis of male fertility in Cx-knock out and Cx-knock in mice
Consequences on spermatogenesis References
KO Cx26 Unknown since embryonic lethality [89]
KO Cx31 No effect on spermatogenesis [90]
KO Cx32 No effect on spermatogenesis [91]
KO Cx33 Unknown ( embryonic lethality?)
KO Cx37 No alteration of spermatogenesis
but female are sterile
[98]
KO Cx40 No alteration of spermatogenesis [92–94]
KO Cx43 Germ cell deficiency in fetal testis
and in postnatally grafted testis
[84,85]
KO Cx46 No alteration of spermatogenesis [95]
KO Cx47 No alteration of spermatogenesis [96]
KO Cx50 No alteration of spermatogenesis [97]
Cx43 KI 32 Alteration of spermatogenesis
(Sertoli-cell-only syndrome)
impaired testicular function due to testicular
vascular anomalies
[87]
Cx43 KI 40
Double KO [99]
Cx37/Cx40
KO Innexin 4 Reduced number of spermatogonia
in Drosophila
[54]
Seminiferous tubules showing Sertoli-cell-only syndrome are totally devoid of
germ cells. In mice Cx43KI32 and Cx43KI40, the coding sequence of the Cx43
gene is substituted by the coding sequences of Cx32 or Cx40.
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Bruzzone, a lack of the substitute Cx to structure gap junction
channels with other Cxs, the establishment of impaired
communication between Sertoli and germ cells and/or changes
in signaling molecules that pass through these heterotypic
channels or in the gating properties of these channels, could be
responsible for this defect [88]. The essential role of gap
junction proteins in spermatogenesis has been also supported
by other studies in invertebrates. It has been reported that
Drosophila males carrying a null mutation in the zero
population growth (zpg) locus that encodes a germ line-
specific gap junction protein (innexin 4) were sterile with
hypotrophic testes that contain reduced numbers of early germ
cells: stem cells or early spermatogonia [54].
In contrast to Cx43, knock-out mice for other Cxs did not
show testicular abnormalities. Mice homozygous for targeted
deletion of Cx26, Cx31, Cx32, Cx40, Cx46, Cx47 and Cx50
genes showed normal fertility [89–97]. Although Cx37-
deficient mice were infertile because of abnormal development
of both ovocytes and ovarian follicles, Cx37/ male mice
exhibited normal spermatogenesis [98]. Targeted double Cx
mutants defective in Cx37 and Cx40 displayed impaired
testicular function with spermatogonia vacuolar degeneration
and necrosis of the testicular tissue [99]. However, these
testicular defects in Cx37/ Cx40/ mice were due to
testicular vascular anomalies rather than direct alteration of
spermatogenesis.
Gap junctions may be implicated in different testicular
functions. During fetal testicular development, the possibility
that Cx43 may be required for germ cell migration and
targeting to the gonads has been suggested in light of data
demonstrating a role of Cx43 in the migration of other cell
types [100,101]. Whether such specific effects request cell–
cell coupling via gap junctions or is independent of this
classical role of Cx in the formation of intercellular channelsneed to be explored [102–104]. During the first weeks of
postnatal life, it is tempting to speculate that Cx43 is
implicated in the thyroid hormone control of Sertoli cell
proliferation [76]. During adulthood, a potential role of gap
junctions in maintaining normal germ cell proliferation may
be hypothesized since testicular microinjection of oleamide, a
well-known inhibitor of GJIC, significantly reduced the
number of germ cells within seminiferous tubules of the
injected testis (Fig. 4). Whether this effect results from altered
synchronization of testosterone synthesis by Leydig cells or
from disruption of homocellular and/or heterocellular gap
junctions within the seminiferous epithelium or both remain
to be clarified. In light of immunological and physiological
studies, there is now evidence that Cx43 gap junctions may
form a transversal and longitudinal intercellular communica-
tion network, corresponding to the initial syncitium-like
organization within seminiferous tubules, which allows the
coordination of Sertoli cell metabolism. Sertoli cells, through
intercellular channels, would ensure metabolic and signaling
coupling to germ cells and allow the synchronization of male
germ cell proliferation and differentiation [37,38]. This
possibility could be considered in light of data in the cerebral
cortex where gap junctions are implicated in the regulation of
neural progenitor cells proliferation and differentiation during
development [105].
3.6. Effect of toxicants on GJIC and connexins in the testis
Within the seminiferous tubules, Sertoli cells are the
primary cellular targets for toxicants that may affect multiple
functions of this cell type [106]. Thus, the possibility that Cxs
could be one of the molecular targets for the deleterious
effects of compounds which affect spermatogenesis has been
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tive agent, impaired both junctional permeability for fluores-
cent dyes and junctional electric conductance in primary
culture of Sertoli cells [107]. Environmental chemicals, such
as ethane 1,2-dimethane sulphonate (EDS), hexachlorocyclo-
hexane (lindane), dichlorodiphenyltrichloroethane (DDT), 1,3-
dinitrobenzene (DNB), alkylphenols also affected Cx43
mRNA and protein levels in Sertoli cells of different species
[52,108–110]. Other chemical compounds with known estro-
genic effects were able to reduce immunoreactive Cx43 levels
in Sertoli and Leydig cells [111]. For these authors, Cx43
might serve as a marker gene to identify chemicals with
estrogenic effects in the testis. The detailed mechanism(s)
whereby these different testicular toxicants affect gap junc-
tional coupling and germ cell proliferation are not entirely
known. A reduced phosphorylation of Cx43 linked to an
inhibition of apoptosis in Sertoli cells exposed to phthalates
have been hypothesized for explaining the inhibition of GJIC
[112]. We demonstrated that lindane impaired GJIC by
inducing concomitantly Cx43 phosphorylation and ERK
activation, and by promoting Cx43 delocalization from the
cell membrane to the cytoplasm [35,108,109]. Defects on Cx43
gap junction could also be mediated through inhibition of the
p38-MAPK pathway as reported in a murine Sertoli cell line
(TM4) exposed to alkylphenol [113].
3.7. Gap junction and connexin expression in human testicular
diseases
Previous morphological studies reported severe alterations
of testicular gap junctions in human pathological testes with
impaired spermatogenesis. By means of freeze-fracture
analyses, no gap junctions were found between Sertoli cells
in feminized testis, but these membranous structures were
frequently observed between Leydig cells [114]. Other
authors described the presence of atypical gap junctions in
the seminiferous tubules of infertile azoospermic and oligos-
permic patients [115]. In two other studies, it has been
reported that the number of gap junction-like cell membrane
specializations was reduced in hypo- or aspermic patients
[116] and that these structures were totally affected in men
with seminiferous tubules exhibiting SCO phenotype [117].
Structurally normal gap junctions are observed in testes of
children aged between 5 and 12 years affected by leukaemiaTable 3
Diseases of the male genital tract associated with altered expression of Cxs
Diseases
Secretory azoospermia (spermatogenic arrest) Sertoli cell only syndromea
Testis cancer CIS, seminoma, seminoma c
Leydig cell tumor and tumo
Prostatic tumor Benign prostatic hyperplasia
Adenocarcinoma
Malignant prostate epithelial
a Sertoli cell syndrome is characterized by seminiferous tubules, totally depleted
b BLT-1 murine Leydig tumor cell line.
c PC-3, LNCap, DU-145, ALVA-31, TSU-Pr1 and RWPE-2 human prostate cancand chemotherapy does not affect the morphology of Sertoli
cell contacts [118].
Data which report altered Cx expression in pathological
human testes are summarized in Table 3. In patients with SCO
syndrome, Cx43 protein was undetectable within seminiferous
tubules [30]. Our recent findings indicate that the disappear-
ance of Cx43 protein within the seminiferous tubules of these
patients was concomitant with a decrease in testicular Cx43
mRNA levels while Cx43 transcripts and protein were
maintained in Leydig cells [31]. These data suggested that
Cx43 alteration, which was probably due to a defect in the
maturation of Sertoli cells, could be used as a biological marker
of Sertoli cell dysfunction [31,61].
Impaired GJIC and Cx dysfunction are currently associated
with the effects of carcinogens and oncogenes [119]. It has
been reported that this feature is typical of numerous
neoplastic tissues (reviewed in Ref [33,120,121]). By means
of immunohistochemistry, Brehm et al. demonstrated that
Cx43 was absent in human testis infiltrated with carcinoma-
in-situ or in seminoma [49] while its presence was evidenced
in normal control testis [30,31]. In other studies, Cx43 mRNA
and protein were normally detected in a group of pure
testicular seminoma and in a seminoma cell line [33,122].
However, fine immunolocalization analysis indicated that
Cx43 was aberrantly detected within the cytoplasm of
seminoma cells instead to be localized, at the cell plasma
membrane level. In transgenic mice, which develop Leydig
cell tumors, we observed reduced testicular Cx43 levels and
aberrant localization of the protein [123]. Analysis of the
kinetic of Cx43 behavior during early and advanced stages of
Leydig cell tumorigenesis allowed us to propose Cx43
delocalization as an early event of uncontrolled cell prolifer-
ation in the pathological testis. In contrast to Cx43, which
was dramatically affected, two other Cxs (Cx26 and Cx40)
were up-regulated in tumoral testicular tissues. Cx26 was
undetectable in normal human testis but displayed a strong
intracytoplasmic Sertoli cell staining in infiltrated tubules with
spermatogonial arrest or CIS-only [49]. It is interesting to
parallel this observation with previous data in human breast
showing that Cx26 expression was strengthened in proportion
to the grade of malignancy [124]. In a recent study, it has
been reported that Cx40 mRNA levels increased in testicular
seminoma as compared to normal human testis [51].
Although the reasons for the alteration of Cx26 and Cx40Connexin References
Cx43 [31]
ell line Cx26, 43 [33,49,122]
ral Leydig cell lineb Cx43 [123]
Cx43, 32 [141]
Cx26, 32, 43 [132,133,141,146]
cell linesc Cx43, 32 [131,139,140,142,143,146]
in germ cells, in which only Sertoli cells are present.
er cell lines.
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possibility that these two Cx would be considered as potential
new diagnostic markers for testicular germ cell tumors has
been hypothesized.
4. Gap junction and connexin expression in the epididymis
and seminal vesicles
4.1. Epididymis
The formation of mature germ cells involves not only their
proliferation, meiosis and differentiation during spermatogen-
esis within the seminiferous tubules but also their final
maturation during transit in the initial segment, the caput, the
corpus and the cauda of the epididymis. In the epididymal
tubule, spermatozoa acquire both fertilizing capacity and
progressive motility. The presence and the physiological role
of gap junctions in these latter processes are still poorly
understood.
Gap junctions were first identified by freeze fracture
electron microscopy between adjacent epididymal principal
cells at their apical and lateral margins [125,126]. Immunore-
active Cx43 based gap junctions were localized between
principal and basal cells but not between adjacent principal
cells [127]. More recently, by using RT-PCR and restriction
enzyme mapping analyses, the presence of multiple Cx
mRNAs (Cx26, Cx30.3, Cx31.1 and Cx32) were reported in
the rat epididymis [128]. In addition, these authors demon-
strated that the expression of these Cxs was segment-specific,
age-dependent and that their localization varied within the
tissue. The possibility that Cx26 and Cx43 could play a major
role during differentiation of the epididymal epithelium and
that GJIC could be crucial to epididymal function has been
suggested [129].
There is evidence that differential regulation of mRNA or
protein levels occurs along the epididymis. In the adult rat
epididymis, Cx43 expression was androgen-dependent in the
initial segment of the epididymis [127] and thyroid
hormone-dependent in the proximal regions of the epididymis
but not in the cauda epididymidis [76]. The reasons why
androgens and thyroid hormones preferentially regulate Cx
expression in different regions of the epididymis are presently
unknown.
4.2. Seminal vesicles
The seminal vesicles join the ampulla of the deferens to
form the beginning of ejaculatory ducts. Histologically, seminal
vesicle epithelium is constituted by highly specialized colum-
nar cells demarcated from its attached stroma (primarily
smooth muscle). Seminal vesicles secrete a great variety of
products that are essential in male fertility. To date, only one
report demonstrates the presence of Cx32 mRNA and protein
in seminal vesicles of adult rats and the absence of Cx43 and
Cx26 in this exocrine gland [130]. However, the precise
cellular localization of Cx32 and its physiological role were not
yet determined.5. Gap junction and connexin expression in the prostate
5.1. Connexins in the prostate
In the prostatic epithelium, gap junctions which are present
between secretory luminal and basal cells can coordinate the
activities between the two cell types [130]. Cx32, Cx40 and/or
Cx43 were identified as major constituents of gap junctions in
prostate tissue and in primary prostate epithelial cells. In the
adult rat prostate, Cx32 and Cx26 were found on secretory
epithelial cells, but Cx43 was not detected [130]. Reports on
analysis of Cx expression in normal adult human prostate are
controversial. While some investigators found Cx32 and no
Cx43 expression [131,132], others reported the presence of
Cx43 in benign prostate cells [133]. There is evidence that
Cx43 is expressed in undifferentiated and mature basal cells as
well as urogenital sinus mesenchymal cells, whereas Cx32 is
expressed by differentiated prostate epithelial cells [134]. For
both epithelial and mesenchymal cells, the ‘‘switch’’ from
Cx43 to Cx32 expression appears to be associated with
prostatic differentiation. Immunohistochemical analysis
revealed that Cx26 was detected not only between adjacent
basal and adjacent luminal cells but also between basal and
luminal cells. In contrast, Cx43 was localized between adjacent
basal cells and between basal and luminal cells but not between
adjacent luminal cells [135]. The presence of Cx43 has been
also recently demonstrated in interstitial cell of the prostate
[136]. For these authors, interstitial cells could function as
pacemaker cells generating slow wave potentials mediated
through Cx43 gap junctions and conducting to the smooth
muscle tone of the prostate.
5.2. Hormonal control of connexins in the prostate
It is well recognized that in steroid sensitive organs, Cx
expression is regulated by steroid hormones including andro-
gens and estrogens. Recent data showed that castration was
associated with both a marked increase in Cx43 expression and
an induction of apoptosis in the prostate gland cells and that the
treatment of animals with testosterone or DHT abolished the
castration-induced Cx43 expression and prevented apoptosis
[137]. Thus, it has been postulated that Cx43 might participate
in prostate involution. The findings that Cx32 was not affected
in the same condition by androgens led to suggest that Cx43
might mediate some of the critical aspects of prostate epithelial
cell survival and proliferation. Since no androgen-responsive
element was identified in the Cx43 gene, it is possible that the
transcriptional effect of androgens on Cx43 gene could be
mediated through AP, cAMP and Sp sites that are present in the
Cx43 promoter. There is also strong evidence that estrogens
control Cx expression in prostate tissue. Indeed, alteration in
estrogen receptors was associated with impaired expression of
gap junction molecules [138]. Neonatal estrogenization of the
prostate increased Cx43 and decreased Cx32 expressions that
may result in defective cell–cell communication [134]. For
these authors, the altered ratio Cx43/Cx32 could reflect a
‘‘switch’’ from differentiation to dedifferentiation of prostate
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associated with altered GJIC, has been also reported in the non-
tumorigenic human prostate epithelial cell line after exposure
to estrone [139,140]. Whether these effects are classically
mediated through estrogen response element or AP-1 site, or
imply activation of cAMP-dependent signal transduction path-
ways remains to be elucidated.
5.3. Connexins and prostatic diseases
Like the majority of neoplastic cells, prostate tumor cells
exhibit impaired GJIC. In contrast to human benign prostatic
hyperplasia, reduced Cx43 and Cx32 expressions were
reported in prostate carcinoma cells (Table 2) [133,141,142].
The altered Cx43 and Cx32 expressions in prostate cancer
samples might lead to aberrant and uncontrolled epithelial
growth and probably have a role in dedifferentiation and tumor
progression. As prostate tumor progress to more undifferenti-
ated stages, Cxs were aberrantly localized in the cytoplasm and
a loss of Cx expression was observed in advanced stages of
carcinoma [132]. Studies with human prostate cancer cell lines
revealed that the major cause of the altered GJIC in these cells
was due to impaired trafficking of Cxs rather than their
inability to form gap junction [143]. By using nontumorigenic
and tumorigenic human prostate epithelial cell lines, it has been
reported that an increase in the Cx43/Cx32 ratio might restore
GJIC in junctionally-deficient cells providing a basis for the
development of new strategies for the prevention and treatment
of human prostate cancer [139,140,144]. Similarly, forced
expression of Cx26 on three human prostate cancer cell lines
led to an inhibition of tumoral cell growth that may be
reinforced by combining gene therapy with chemotherapy
[145]. Recently, a novel mechanism for adhesion regulation by
a gap junction-independent Cx26 function that correlates with
prostate disease progression has been described [146].
6. Gap junction and connexin expression in the Corpus
cavernosum
Modulation of smooth muscle tone, through myocyte
contraction or relaxation, is critical for maintaining the
physiological functions of diverse vascular and non-vascular
organs of the body. The penis is a vascular organ and changes
in the contractile status of corporal and arterial govern the flow
of blood to and from the penis and have a major impact on
erectile capacity. In concert with the autonomic nervous system
and myogenic intracellular signal transduction mechanisms, the
regulation of this process is dependent on the presence of gap
junctions, between corpus cavernosum smooth muscle cells,
that allow the formation of a syncytial cellular network
coordinating uniform corporal smooth muscle tone. Gap
junctions and the major component of these structures, Cx43,
have been characterized in situ and in cultured corporal smooth
muscle [147–152].
Emerging evidence suggests that, outside impairment of K+
channel activity in cavernosal and arterial smooth muscle cells,
a reduced passive conductance of electrical signals due to gapjunction impairment, could be responsible to erectile dysfunc-
tion (reviewed in Ref. [153]). Although a marked increase in
Cx43 mRNA levels was reported in corpora tissue of diabetic
rats [154] and a negative correlation was observed between
Cx43 levels and patient age [155], there is today evidence that
gap junctions in the penis are not directly influenced by erectile
diseases and that Cx43 is constitutively synthesized in this
tissue [156].
7. Conclusions and perspectives
Gap junctions and Cxs appear as a constant in the male
reproductive tract and can play a major role in several functions
including germ cell proliferation and differentiation, and in
modulating the initiation and maintenance of smooth muscle
tone in different structures of the male tract. Although there is
at present no direct demonstration that impaired Cx expression
may be involved in pathogenesis of human male sexual
function, it is likely to suspect Cx dysfunction(s) in some
testis and prostate diseases (spermatogenic arrest, seminoma,
prostatic adenocarcinoma) and in the physiopathology of the
human erectile response. The development of strategies to
restore normal GJIC in affected cells of the male genital tract
will be required after precisely determining the nature of Cx(s)
implicated, Cx gene transfer to these cells and/or to develop
effective pharmacological agents. Such strategies have been
initiated in different domains of male reproductive pathology
such as prostate disease [140] and erectile dysfunction [156].
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